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Two subtypes of receptors for serotonin (5-hydroxytryptamine; 5-HT) are known to stimulate inositol(l,4,5)-trisphosphate production, the 5-HT,, 
and 5-HT, receptors. In this study we investigated the ability of 5-HT,, receptors, transiently expressed in COS 7 cells, to functionally interact with 
protein kinase C-a, the indigenous (phorbol ester-responsive) isoform of the enzyme in those cells. Serotonin caused translocation of the [‘Hlphorbol 
12,13-dibutyrate (PDBu) binding site of PKC-a from the cytosolic to the membrane fraction in a Ca”-dependent manner which was prevented 
by the 5-HT,, receptor antagonist mianserin. The hpid activators of PKC, PDBu and 1,2-dioctanoyl-sn-glycerol (DOG) also caused translocation, 
but through a mechanism apparently quite independent of Ca”. 
Serotonin; 5-HT,, receptor; Expression; Protein kinase C 
1. INTRODUCTION 2. MATERIALS AND METHODS 
2.1. Chemicals 
The G7 family of receptors is a large group consisting 
of proteins with seven transmembrane spanning re- 
gions. Their actions are mediated through G proteins 
which stimulate or inhibit a number of second messen- 
ger pathways or ion channels. Serotonin, or 5-hy- 
droxytryptamine (5-HT), is the ligand for at least five 
members of this family [l]. One of these, the 5-HT,, 
receptor, is known to stimulate production of inositol 
1,4,5 trisphosphate [2] which causes release of intracel- 
lular Ca” [3]. This receptor has been identified in neural 
tissue [4-61 but is most highly expressed in choroid 
plexus [4,7]. Recently the receptor gene was isolated by 
expressing a rat choroid plexus cDNA library in Xen- 
opus oocytes [8]. Within this system the expressed recep- 
tor and a partial clone [9] affect Ca’+ dependent Cl- 
channels [lo] and also K’ channels [ll]. When the re- 
ceptor was expressed in rat fibroblasts, Ca2’ was re- 
leased from intracellular stores [12], indicating that a 
similar mechanism of action was involved there to that 
operating endogenously and in transfected oocytes. The 
aim of this study was to use transient expression of the 
receptor in transfected COS 7 cells to investigate recep- 
tor-mediated stimulation of PKC, and in particular 
whether the 5-HT,, receptor can functionally activate 
the CI isoform of PKC. 
Tissue culture media were obtained from Life Technologies, Paisley, 
UK. Standard laboratory chemicals of Analar grade were obtained 
from BDH Chemicals Ltd, Poole, UK, [20-‘H(N)]PDBu 
(spec.act. = 19.1 Ci/mmol) and ATP-y-“S (spec.act. = 1256 Ci/mmol) 
which were purchased from Du Pont, Dreieich, Germany. DEAE 
dextran was obtained from NBL (Cramlington, UK) or Promega Ltd 
(Southampton, UK). All other reagents and chemicals were obtained 
from Sigma Chemical Co Ltd, Poole, UK, unless otherwise indicated. 
2.2. Cell culture 
COS 7 cells (gift of Dr Janet Allen) were grown in DMEM supple- 
mented with 10% newborn calf serum and 100 U/ml each of penicillin 
and streptomycin, in a humidified atmosphere of 95% sir/5% CO> at 
a constant temperature of 37°C. and were passaged every 34 days. 
Cells for transfection were trypsinised the day before the experiment 
and plated at a density of approximately 50-60% in 75 cm’ flasks. 
2.3. Preparatron of cDNA 
Correspondence address: R. Mitchell, MRC Brain Metabolism Unit, 
University Department of Pharmacology, 1 George Square, Ed- 
inburgh, EH8 9JZ. UK. Fax: (44) (31) 667 0240. 
The coding region for the rat 5-HT,, receptor was included in a 3.0 
kbp cDNA insert in the EcoRI site of the plasmid, pMV7SRlc, a gift 
from Dr D. Julius [8]. The EcoRI insert was excised from a low meltmg 
point gel, purified with Geneclean II Sephaglass resin (Stratech, 
Luton. UK) and the ends filled in using T, DNA polymerase (Boehrin- 
ger Mannheim, Lewes, UK) and a mixture of deoxynucleotides (USB, 
Cambridge, UK) [13]. The cDNA was then ligated to &XI linkers 
(British Btotechnology Ltd, Cowley, UK) and subcloned into the 
BsrXI site of the expression vector pCDM8; a gift from Dr B. Seed, 
[14]. The subsequent clones were restricted with various endonucleases 
to verify which clone had the receptor cDNA in the proper orientation. 
The selected clone was grown up in 5 ml overnight culture using Luria 
broth supplemented with 7.5 pug/ml tetracycline and 12.5 .&ml ampi- 
cillin and extracted according to the alkaline lysis miniprep method 
[13]. After a further precipitation step the plasmid was then used to 
transfect cells. The cDNA inserted in the opposite orientation was 
used as one of the controls. 
*Present address: Department of Biochemistry, S3-1, Institute of Bio- 
chemistry and Cell Biology, Syntex Discovery Research, Palo Alto, 
CA 94304, USA 
2.4. Transfection of cells 
Cells were washed two times with OptiMEM supplemented with 100 
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U/ml each of streptomycin and penicillin at 37°C prior to exposure 
to transfecting medium for 4 h. The transfecting medium consisted of 
OptiMEM/penicilhn/streptomycin, 400&ml DEAE dextran, 100pM 
chloroquine phosphate and approximately l/5 of an overnight culture 
miniprep/flask. This was replaced with 10% DMSO in DMEM/peni- 
cillin/streptomycin for 2 min, then DMEMllOZ newborn calf serum/ 
penicillin/streptomycin or DMEMR% UltraSerG/penicillin/strepto- 
mycin. Cells were harvested 72 h later. The efficiency of transfection 
was assessed using a pCHll0 ,+galactosidase gene construct and 
indicated that approximately 10% of the cells expressed B-galactosi- 
dase activity (data not shown). 
2.5. Phorbof binding assay 
Cytosohc 13H]PDBu binding was performed in a method similar to 
that described by Leach et al. [15]. After stimulation for 15 min in 
culture flasks, the medium was aspirated and cells were scraped into 
0.5 ml of ice-cold ‘Kuo’ buffer (20 mM Tris-HC1 (pH 7.5) 50 mM 
2-mercaptoethanol, 2 mM EDTA and 1 mM phenylmethylsulphonyl 
fluoride) containing 0.01% leupeptin + 20 PM transepoxysuccinyl-r- 
leucylamido-(4-guanidino)butane (E-64) and homogenised. Samples 
were centrifuged (38,000 x g, 20 min. 4’C). The supematant and pellet 
were carefully separated and the pellet was re-homogenised in 0.5 ml 
“Iris-BSA’ (50 mM Tris-HCl) (pH 7.4), 4 mg/ml essential fatty acid- 
free bovine serum albumin. While membrane binding was carried out 
in Tris-BSA, cytosolic binding assays additionally contained 1 mM 
CaCl, and 75 mM ma~~iurn acetate and 1.25 mg/mI sonicated 
phosphatidyIse~ne, sodium salt (Lipid Products Ltd, Nutfield, UK). 
Assays were conducted in a total volume of 25Opl(30 min, 37”Q with 
5 nM [3H]PDBu (approximately 0.03 pCi per tube) and dimethylfor- 
mamide (0.5% final) or 10 PM PDBu in dimethylformamide for total 
and non-specific binding measurements, respectively. Tissue samples 
gave a total binding of less than 10% of total radioactivity present. 
Protein was precipitated at 4°C by the addition of 100~1 of 12 mg/ml 
bovine y-globulin and 300 ~1 of 24% polyethyleneglycol 8000 in 50 
mM Tris-HC1 (pH 7.4). After 20 min, assay tubes were centrifuged 
(12,000 x g, 5 min, 4”C), the supematant aspirated and the ‘H radio- 
activity in each pellet determined after solubilisation. 
After stimulation, cells were harvested and initially treated as for 
the [‘H]PDBu binding assay. The membrane fraction from the 
38,000 x g centrifugation was resuspended in ‘Kuo’ buffer with pepti- 
dase inhibitors, then both it and the cytosolic fraction were made up 
to 0.1% Triton X-100 and stirred for I h at 4°C to solubilise the 
membrane-associated PKCs. Samples were again centrifuged at 
38,000 x g for 20 min at 4°C. The PKCs present in the supematants 
were partially purified by loading onto a diethylaminoethyl cellulose, 
DE52 (Whatman Biosystems Ltd, Maidstone, UK) (pH 7.5)Joaded 
Bio-Rad Poly-Prep Chromatography column (Bio-Rad Laboratories, 
Richmond, CA, USA) prewashed with 9 column volumes of ‘Kuo’ 
buffer + 0.01% leupeptin + 20 PM E64. The sample was allowed to 
run through before washing with a further 9 column volumes of ‘Kuo’ 
buffer + 0.01% ieupeptin + 20 PM E64. The partially purified PKCs 
were eluted with 3 column volumes of ‘Kuo’ buffer + 0.01% leupeptin 
+ 20 PM E64 supplements with 150 mM NaCI. 
PhosphatidyIse~ne v sicles were prepared by sonication in ice-cold 
‘Tris-EGTA’ (20 mM Tris-HCI (pH 7.5) + 0.5 mM EGTA) at a stock 
concentration of 4OO&ml. The suspension had 0.16% Nonidet P-40 
(Calbiochem, Nottingham, UK) added and was vortexed for 2 min 
before allowing to settle at room temperature for a minimum of 15 
min. 
All assay dilutions were performed in Tris-EGTA. Partially purified 
cytosol(150 mM NaCl eluate) was added to eppendorf tubes contain- 
ing (final concentrations): 1.25 mM MgCI,, 100 &ml phosphatidyl- 
serine + 0.04% Nonidet P-40, 1.25 mpjml lysine-rich histone III-S as 
substrate. 100 PM ATP-y-S containing ATP@S (approximately 
0.18 PCiltube). Assay tubes contained PDBu or 1,2-dioctanoyl-sn- 
glycerol (Sigma) DOG dissolved with ~~ethylfo~~ide (0.05% 
final) in Tris-EGTA (or dimethylfo~amide in Tris-EGTA alone for 
control measurements), 600 PM CaCi, (100 ,uM final free Ca2’) or 5 
mM EGTA (< 3 nM final free Ca2’), kinase inhibitors or control 
solvent where appropriate. Cytosol was added to pre-warmed (30°C) 
tubes (final assay volume = 100 ~1) and reactions were started by brief 
centrifugation in a bench-top centrifuge and incubated for 15 min at 
30°C (a time at which enzyme kinetics were determined to be linear). 
Reactions were stopped by addition of 20 ~1 of ice-cold 0.1 M ATP 
in 0.1 M EDTA (pH 7.0) followed by being placed on ice for 20 min 
then spun (16,000 x g, 15 min, 4°C) 50 ~1 of each stopped sample was 
spotted onto a 4 cm2 Whatman P81 cellulose phosphate ion-exchange 
chromatography paper (Wha~an) and washed (3 x 2 min, room tem- 
perature) in 10 ml of 75 mM H,PO,. Papers were dried overnight in 
a fume hood before counting in liquid ~intillation fluid for ?S radio- 
activity. 
3. RESULTS 
The 5-HT,, receptor cDNA was inserted into the 
pCDM8 vector and transiently expressed in COS 7 cells. 
After 72 h these cells were assayed for functional recep- 
tors by stimulating with serotonin and determining the 
relative number of phorbol binding sites which had 
translocated from cytosol into the membrane, as com- 
pared to basal levels. Table Ia shows that 20 ,uM sero- 
tonin induced only a modest translocation of specific 
[3H]PDBu binding sites into the membrane (42% com- 
pared to 32% in controls). The effect of 300 nM PDBu 
was much greater, with 79% of sites appearing in the 
membrane fraction after PDBu treatment. Cells which 
were not exposed to serotonin had an unexpectedly 
large proportion (32%) of the [3H]PDBu binding sites 
within the membrane fraction. Treatment with the 5- 
HT,, antagonist, mianserin, reduced this basal migra- 
tion of [3H]PDBu binding sites into the membrane frac- 
tion. It has been reported [16] that serum supplemented- 
medium contains sufficient serotonin to partially acti- 
vate the 5-HT,, receptor in transfected fibroblasts. 
Thus, in subsequent experiments transfected cells were 
no longer cultured in medium supplemented with new- 
born calf serum, instead the synthetic serum substitute 
UltroSerG was used. Table Ib shows that serotonin also 
appeared to cause a small translocation of PKC enzyme 
activity into the membrane fraction in comparison with 
control or mianserin-treated cells. COS 7 cell extracts 
contain very high basal histone kinase activity (which 
is in part sensitive to the selective PKC inhibitor [17] Ro 
31-8220; data not shown). This may be due to the pres- 
ence of the constitutively-active cleaved catalytic do- 
main of PKC, resulting from the action of calpain-like 
activity in the cells and indeed considerable amounts of 
low molecular weight fragments of PKC S, E and 6 were 
detected when they were expressed in COS cells [18]. 
Alternatively, the presence of PKC 5 [19] which is acti- 
vated by phosphatidylserine with no requirement for 
phorbol esters [20] may be responsible. Due to the much 
better signal to noise ratio, only the translocation of 
[3H]PDBu binding sites was pursued in further experi- 
ments as an index of receptor-mediated influence on 
PKC. 
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Table I 
Translocation of PKC in COS 7 cells transfected with the cDNA for 
the S-HT,, receptor and cultured in 10% newborn calf serum 
(4 [3H]PDBu binding (dpm per assay tube) 
Treatment Cytosol Membrane % in mem- 
brane 
Control 1705 * 349 805 + 155 32 + 7 
Serotonin (20 PM) 1194 i 295 854 + 108 42 rt 7 
Mianserin (100 yM) 2278 f 295 301 & 88 12 rtr4 
PDBu (300 nM) 463 + 210 1701 + 186 79 + 8 
(W PDBu-induced kmase activity (dpm per assay 
tube) 
Treatment Cytosol Membrane % in mem- 
brane 
Control 1420 k 205 137 + 74 9t6 
Serotonin (20 PM) 988 + 164 246 f 106 20 rt 9 
Mianserm (100 ,uM) 1322 + 199 97 f 65 7+5 
Part a shows specific eqmlibrium binding of [rH]PDBu as dpm per 
assay tube in cytosol and membrane fractions prepared from trans- 
fected COS 7 cells treated as indicated for 15 min immediately prior 
to homogenisation. Values are means ? S.E.M. from 3 separate deter- 
minations carried out in duplicate. Typical values for control total and 
non-specific binding were - 950 dpm per tube respectively for cytosol 
and - 1900 and - 700 respectively for membranes. Part b shows the 
Ca2’-dependent PDBu (1 PM)-evoked [“Sjthiophosphorylation ofhis- 
tone III-s as determined in a mixed-micelle, PS-dependent assay for 
partially purified PKC. Values are means f S.E.M. dpm incorporated 
per assay tube from three separate determinations carried in duplicate. 
Typical control values in the absence of PDBu were - 4000 and - 500 
dpm per assay tube, respectively, for cytosol and membrane fractions. 
Table II shows that in serum-free conditions the basal 
proportion of [3H]PDBu binding sites within the mem- 
brane fraction is low (12%) and not significantly differ- 
ent from transfected cells incubated with mianserin 
alone. When exposed to serotonin, a clear translocation 
was recorded with 35% of the [3H]PDBu binding sites 
within the membrane. This response was prevented by 
mianserin. It is not known whether higher concentra- 
tions of serotonin would have elicited a greater re- 
sponse. Cells which were transfected with receptor 
cDNA inserted in the antisense orientation (Table IIb) 
and cells which were exposed to transfection without 
receptor cDNA (Table 11~) were not responsive to sero- 
tonin. In all of these experiments, translocation was 
observed after treatment with PDBu (300 nM) or DOG 
(200 PM) indicating that the cells would in principle 
have been capable of responding to any serotonin-elic- 
ited signal. Interestingly, DOG (200 PM) always caused 
much less translocation of [3H]PDBu binding sites than 
did PDBu (300 nM), even though these concentrations 
produce equivalent effects in a model of PKC-mediated 
facilitation of Ca2+ channels [21]. 
In order to assess whether the influence of the 5-HT,, 
receptor on PKC was dependent on calcium, experi- 
ments were carried out in medium depleted of Ca’+ (to 
-100 nM) by the addition of EGTA (3 mM) to the nor- 
mal medium (1 .X mM Ca’+). Table III indicates that 
receptor-elicited translocation of [3H]PDBu binding 
sites does indeed show a dependence on calcium levels 
but in clear contrast that responses elicited by PDBu or 
DOG are unaffected by Ca*‘-depletion. 
4. DISCUSSION 
The present results illustrate, by demonstrating cou- 
pling to a downstream signalling response, that the 5- 
HT,, receptor cDNA can be successfully transfected 
and expressed in COS 7 cells in a functional state. Sero- 
tonin (5HT) was able to elicit translocation/activation 
of PKC specifically in response to 5-HT in a manner 
sensitive to a 5-HT,, receptor antagonist mianserin. We 
do not know which of the several agonist affinity states 
of the 5-HT,, receptor expressed in fibroblasts [22,23] 
is functionally involved in the present response. Both 
the cell-permeant diglyceride, DOG and the synthetic 
activator of the diglyceride reco~ition site on PKC, 
PDBu also caused translocation of PKC in these cells. 
Table II 
Translocation of PKC in COS 7 cells transfected with the cDNA for 
the 5-HT,, receptor or controls and cultured in serum-free conditions. 
(a) [3H]PDBu specific binding 
(dpm per assay tube) 
Treatment Cytosol Membrane % m mem- 
brane 
Control 9260 f 1030 1272 i 270 1224 
Serotonm (20 PM) 6291 f 825* 3386 + 482* 35 -t 6 
Mianserm (100 PM) 10276? 1332 1651 ? 350 14* 5 
Serotonin + mianserin 8703 f 906** 1755 t 355** 17 zt 4 
DOG (200 PM) 6347 + 980* 3294 + 653* 34rt 8 
PDBu (300 nM) 2022 + 627* 2935 + 781* 59rt 13 
(h) 
Control 
Serotonm (20 PM) 
DOG (200 PM) 
PDBu (300 nM) 
7203 k 1408 1481 + 567 17t6 
7860 + 1294 1756 + 601 18 + 7 
4484 i 1830 3546 f 1215* 44 rt 12 
2044 t 1470* 5253 + 897* 72 t 13 
(c) 
Control 
Serotonin (20 pM) 
DOG (200 ,uM) 
PDBu (300 nM) 
6879 + 1075 1680 2 379 20 t 5 
6563 t 988 1785 f 616 21 r7 
3839 f 1379* 2669 2 702 41? 11 
1588 f 979* 3788 f 655* 70 rt 12 
The values represent specific binding of [‘H]PDBu to cytosolic or 
membrane PKC in cells transfected with (a) the 5-HT,, receptor 
cDNA, (b) its antisense control or (c) transfectmg medium alone. All 
results are the means + S.E.M. from 4 separate xperiments carried 
out in duplicate. The statistical significance of changes from control 
(P < 0.05 by Student’s t-test) is Indicated by * and from serotonin 
alone by **. 
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Table III 
Ca”-dependence of PKC translocation in COS 7 cells transfected with 
the cDNA for the 5-HT,, receptor 
Specific [‘H]PDBu binding (8 in 
membrane fraction) 
Treatment + Ca” - Ca*+ 
Control 17f3 19 f 4 
Serotonin (20 PM) 36 f 5* 21 f 6** 
DOG (200 PM) 38 f 5* 41 * 5* 
PDBu (300 nM) 83 + 8* 79* 11* 
The values represent he percentage of specific [‘H]PDBu binding 
recovered in the membrane fraction from experiments conducted as 
in Table II. Cells were cultured in serum-free conditions with either 
normal (1.8 mM) Ca2’ or the addition of 3 mM EGTA 10 min prior 
to and during the challenge with agonist. Results are the 
means f S.E.M. from 5 experiments. Statistical significance of 
changes (P < 0.05, Man-Whitney U-test) is indicated by * (compari- 
son with control unstimulated values) and ** (comparison with corre- 
sponding response in the presence of Ca”). Removal of Ca’+ had no 
effect on the absolute dpm per assay tube in control cells or those 
stimulated with either DOG or PDBu. 
Thus the presence of the response to 5-HT may reflect 
generation of diglyceride as a consequence of agonist- 
stimulation of the receptor, most likely by activation of 
a phospho-inositidase C (PIC). It is not certain which 
isoform of PIC was involved in the response to 5-HT, 
especially since the a subunit of the G protein Gq 
(which has been reported to couple phospho-inositide- 
hydrolysing receptors to activation of PIC j?i [24]) is not 
strongly expressed in COS 7 cells [25]. Nevertheless, 
other G a isoforms that could substitute for Gq a may 
be present allowing activation of PIC via the 5-HT,, 
receptor to occur. 
It has been thought for a number of years that COS 
7 cells expressed only the a isoform of PKC [26] and 
although there is recent evidence that < PKC may also 
be present [19], this isoform appears to have little affin- 
ity for phorbol esters [20] and therefore should not con- 
tribute to the current results. 
Both PDBu and DOG caused clear translocation of 
[3H]PDBu binding sites in COS 7 cells, although the 
effect of DOG (at a concentration maximal in other 
PKC response models [21, 271 was much less than that 
of PDBu. This is entirely consistent with previous re- 
sults which demonstrated that PKC a (predominant 
here in COS 7 cells) shows both a distinctively reduced 
binding affinity and potency of kinase activation with 
respect to short chain saturated diglycerides such as 
DOG but not phorbol esters [27]. 
The relative roles of diglyceride/phorbol ester and 
Ca*’ in the interaction of PKC with membranes remains 
somewhat unclear. It is clear that phorbol esters alone 
readily induce translocation of Ca2+-dependent PKC 
isoforms and act to stabilise the membrane PKC com- 
plex with phospholipid and Ca2’ [28,29]. However, the 
initial interaction of enzyme with phospholipid mem- 
brane appears to be highly dependent on Ca*’ and re- 
quires levels which are certainly in excess of those en- 
countered in the cytosol of resting cells [28-301. Al- 
though one group has provided (indirect) evidence that 
PDBu increased the association of PKC with plasma 
membranes at a range of set Ca2’ concentrations, there 
was no response at all at free Ca*’ concentrations of 230 
nM and below [30], such as would pertain in the cytosol 
of resting cells. However, since all these studies were 
carried out with mixtures of PKC isoforms, it is not 
clear that one could extrapolate directly to responses of 
PKC a, as recorded in the present experiments. 
Whilst DOG and PDBu were able to cause transloca- 
tion of PKC (presumably the a isoform) in a manner 
independent of Ca” (Table III), agonist activation of 
the 5-HT,, receptor was only effective in this response 
in the presence of Ca’+. It is conceivable that such Ca*‘- 
dependence would be apparent with the receptor ag- 
onist rather than the direct PKC activators because 
rather low levels of diglyceride (requiring some synergy 
with Ca” for an adequate ffect) would be produced by 
receptor activation. Nevertheless, translocation to a 
very similar extent caused by addition of exogenous 
diglyceride showed no evidence whatsoever of Ca2’- 
dependence. It is possible though that additional eleva- 
tion of cytosolic calcium in these cells would have fur- 
ther enhanced any submaximal lipid-induced transloca- 
tion response (such as that to DOG). In contrast, DOG- 
induced histone III-s thiophosphorylation by the a 
isoform of PKC is entirely Ca”-dependent [28]; indicat- 
ing that translocation and enzymic activation of PKC 
a are mechanistically quite distinct. Interestingly, acti- 
vation of PKC a by PDBu differs from that by DOG 
in that it can occur partially even in the absence of Ca” 
[27]. Thus, the presumed abilities of the 5-HT,, receptor 
to generate diglyceride and also to elevate cytosolic Ca2+ 
both appear to play some role in its ability to translo- 
cate/activate PKC a. 
Interestingly, expression of this receptor in NIH 3T3 
(but not CCL 39) fibroblasts has been shown to cause 
mitogenic transformation [12, 16, 311, much in the same 
manner as observed in Rat 6 fibroblasts overexpressing 
protein kinase C /II [32]. It seems likely that at least in 
some circumstances and in certain cells, the ability of 
G7 receptors to activate PKC (as investigated here) may 
play an important role in their induction of cellular 
transformation [16]. 
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